Our Litigators of the Week are Eric Dittmann and Kecia Reynolds of Paul Hastings. They have been representing client Viking Therapeutics Inc., a company working on a potential treatment for non-alcoholic fatty liver disease, in trade secret proceedings before the U.S. International Trade Commission involving Ascletis, a Chinese biotech company.